Skip to content


Namenda, Axura, Ebixa (memantine) is a small molecule pharmaceutical. Memantine was first approved as Namenda on 2002-05-15. It is used to treat alzheimer disease in the USA. It has been approved in Europe to treat alzheimer disease. It is known to target glutamate receptor ionotropic, NMDA 2C. Namenda's patent is valid until 2029-03-24 (FDA).
Trade Name Axura, Ebixa
Common Name Memantine
Indication alzheimer disease
Drug Class Antivirals/antiparkinsonians (adamantane derivatives)
Get full access now